Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Connect with us

Hi, what are you looking for?

slide 3 of 2
THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & LifestyleTHE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle

Breaking News

Breaking News

UK watchdog warns Cochlear-Oticon Medical agreement could hurt market.

Demant logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration Demant logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration
Demant logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration Demant logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration

Listen to the article now

On Thursday, Britain’s Competition and Markets Authority claimed Cochlear’s acquisition of Demant’s hearing implants business could hinder competition and raise NHS pricing.

In a statement, the CMA warned that the proposed 850 million Danish crown ($125 million) agreement between two of Britain’s top hearing implant companies could harm patients and raise NHS costs.

Cochlear (COH.AX) and Denmark’s Demant (DEMANT.CO) said they disagreed with the CMA’s findings and would “engage constructively” to address its concerns.

Demant claimed it would “discontinue” Oticon Medical regardless of competition regulators’ findings because it had previously concluded it would never become a global leader in hearing implants.

French Foreign Direct Investment regulations and EU and Australian competition officials are also reviewing the acquisition.

The CMA has until June 5 to complete its investigation of the purchase, which Cochlear claimed would not conclude until June 30.

The regulator claimed the combined business would leave only one provider of passive bone conductive solution (BCS) products in Britain, with a market share far above 90%.


Comment Template

You May Also Like

Business

Cricut Unveils New Crafting Machines: Faster, Cheaper, and More Accurate On February 27, 2025, Cricut, the beloved brand known for its innovative crafting machines,...

Business

**Excerpt:** Apple has unveiled a suite of new child safety features aimed at giving parents greater control over their kids’ app usage. Announced on...

Business

**Excerpt from "The Evolution of Legacy Media: Why It’s Not Dead Yet"** In a world dominated by digital platforms and instant news, Evan Leatherwood,...

Business

**Excerpt:** On February 27, 2025, newly confirmed FBI Director Kash Patel unveiled a groundbreaking proposal: a partnership between the FBI and the Ultimate Fighting...

Notice: The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to our Privacy Policy and our Cookie Policy.

Ok